Russia is fast-tracking a second coronavirus vaccine, moving it quickly through the approval process as the country races to safeguard its population from a second wave and pushes to raise its profile abroad.
Coronavirus
Wall Street Journal: Russia fast-tracks second coronavirus vaccine
An employee wearing protective equipment walks in a passage at the headquarters of Russia's biotech company BIOCAD, which is developing its own vaccine against the new coronavirus and working on another one in cooperation with the country's virus research center in Siberia, Vektor, in Strelna on May 20, 2020.
